SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-029129
Filing Date
2008-05-01
Accepted
2008-05-01 17:15:43
Documents
5
Period of Report
2008-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a08-11682_110q.htm 10-Q 733452
2 CERTIFICATION OF CEO PURSUANT TO SECTION 302 a08-11682_1ex31d1.htm EX-31.1 13936
3 CERTIFICATION OF CFO, SECRETARY AND TREASURER PURSUANT TO SECTION 302 a08-11682_1ex31d2.htm EX-31.2 13251
4 CERTIFICATION OF CEO PURSUANT TO SECTION 906 a08-11682_1ex32d1.htm EX-32.1 6102
5 CERTIFICATION OF CFO, SECRETARY AND TREASURER PURSUANT TO SECTION 906 a08-11682_1ex32d2.htm EX-32.2 6888
  Complete submission text file 0001104659-08-029129.txt   775173
Mailing Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328
Business Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328 678-341-1436
SCIELE PHARMA, INC. (Filer) CIK: 0001106773 (see all company filings)

IRS No.: 582004779 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30123 | Film No.: 08795648
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1